Navigation Links
ResMed Receives Permanent Injunction against APEX in Germany, Continues Enforcement of Patents in Europe
Date:7/28/2014

MUNICH, July 28, 2014 /PRNewswire/ -- ResMed (NYSE: RMD), an innovator and pioneer in developing products for the treatment of sleep-disordered breathing and other chronic respiratory conditions, has won a permanent injunction in Germany against Taiwanese medical device manufacturer APEX Medical Corp. (APEX), prohibiting sales of infringing headgear used on APEX WiZARD 210 and 220 masks.  The judgment was entered by the Regional District Court in Munich, is appealable, and applies throughout Germany. 

The permanent injunction continues a preliminary injunction that was entered by the same court on Nov. 12, 2013.  The court rejected APEX's request to stay the injunction and its challenge to the validity of ResMed's patent.  The judgment also requires APEX to forfeit its inventory of infringing products, to report on its sales of the infringing products, and to pay damages to ResMed.ResMed has also filed separate patent infringement lawsuits in the same court seeking damages and permanent injunctions to stop infringement of other ResMed patents. The trials of those cases will occur in the fall of 2014.  The additional accused products are:

  • The APEX iCH and XT Fit CPAP devices
  • The APEX WiZARD 210 and WiZARD 220 masks
  • "ResMed has a global business built on its investment in research and developments, resulting in products sold worldwide that excel in performance, quality and comfort," said David Pendarvis, ResMed global general counsel and chief administrative officer. "We will continue to defend our investment in intellectual property and pursue all legal remedies to prevent infringement in any country where that infringement exists."

    About ResMed: ResMed changes lives by developing, manufacturing and distributing medical equipment for treating, diagnosing, and managing sleep-disordered breathing, COPD, and other chronic diseases. We develop innovative products and solutions to improve the health and quality of life of those who suffer from these conditions, and we work to raise awareness of the potentially serious health consequences of untreated sleep-disordered breathing. For more information on ResMed, visit www.resmed.com.  Contacts:
    For News Media For InvestorsGretchen Griswold

    Agnes LeeDirector, Global Corporate CommunicationsSenior Director, Investor RelationsO: 858-836-6789

    O: 858-836-5971news@resmed.com

    investorrelations@resmed.com


    '/>"/>
    SOURCE ResMed Inc.
    Copyright©2014 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. ITC Rules Redesigned APEX Humidifier Still Infringes ResMed Patents
    2. ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results
    3. ResMeds New Nasal Pillows System is Our Quietest Yet; Ultra-light AirFit P10 Packs Powerful Performance in Just over 1.5 Ounces
    4. ResMed Announces Conference Call And Webcast To Discuss Second Quarter 2014 Results
    5. BMC to protect its rights in patent fight with ResMed
    6. Apex reagiert energisch auf ResMed Patentklage
    7. ResMed Receives Injunctions against APEX and BMC in Germany, Continues Enforcement of Patents in Europe
    8. ResMed Inc. Announces Record Financial Results For The Quarter Ended September 30, 2013
    9. ResMeds New Nasal Mask Sets the Bar for Comfort and Performance
    10. ResMed Patent Infringement Case Against BMC Advances: International Trade Commission Agrees to Investigate
    11. Apex Fights Back Against ResMeds Patent Litigation
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/19/2017)... HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform ... leadership team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led ...
    (Date:9/12/2017)... and NEW YORK , Sept. 12, 2017 ... performance ratings for global supply chains, has published the first annual edition ... CSR performance of more than 20,400 companies evaluated by EcoVadis, based on ... 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
    (Date:9/9/2017)... , Sept. 9, 2017  Eli Lilly and ... primary and secondary endpoint data for lasmiditan, an investigational, ... which demonstrated statistically significant improvements compared to placebo in ... highlighted today at the 18th Congress of the International ... "The data presented today demonstrate lasmiditan,s potential ...
    Breaking Medicine Technology:
    (Date:9/22/2017)... , ... September 22, 2017 , ... Happy Living’s mission ... time - carries it into the entertaining and delicious worlds of theatre and ... (founder of Happy Living) convinced him to turn his play into a book. The ...
    (Date:9/22/2017)... ... 22, 2017 , ... TopConsumerReviews.com recently awarded their highest five-star ... promote pancreatic health and regulate blood sugar levels . , Preventing diabetes ... negative side effects, and with the changes in today’s healthcare industry, not everyone ...
    (Date:9/22/2017)... ... 22, 2017 , ... Silicon Valley startup Enke Life has ... Their electric toothbrushes aggressively attack oral bacteria by reducing dental plaque and other ... edge Enke technology with a premium timeless design, they want to redefine the ...
    (Date:9/22/2017)... ... September 22, 2017 , ... The freshly released ... doorstep. According to Smart Mart, customers can now order vegetable, fruit, snacks, dairy, ... customers can find clothing at discounted prices. Apart from this, Smart Mart has ...
    (Date:9/21/2017)... Viejo, CA (PRWEB) , ... September 21, 2017 , ... ... been so fun and easy to do. Users can select from up to two ... all with a click of a mouse all within Final Cut Pro X. ...
    Breaking Medicine News(10 mins):